The New Wave of Anti-Trans Legislation Sure Looks a Lot Like Eugenics
By Evan Urquhart,
Slate
| 03. 03. 2021
State-level bills around women’s sports and adolescent medical care would seem to share a common goal.
Photo by Sharon McCutcheon on Unsplash
A huge wave of anti-transgender legislation is coursing through statehouses in the early months of 2021. Bills that have been introduced (often with the same or similar language across states) follow one of two models: Some prohibit trans youth from participating in female-designated sports programs, while others seek to criminalize the provision of age-appropriate, trans-affirming medical care to minors. If you’re wondering why legislators (and the advocacy groups that feed them policy ideas) are focused on these particular issues, it may be useful to consider the concept of eugenics. Yes, it’s a heavy word, evoking some of the more horrific historical misuses of “science,” but think about it: These are bills aimed at cleansing society of the “wrong” sort of people as soon as their difference makes itself visible, and promoting the right sort in their place.
Trans people have been talking about anti-trans measures in the context of eugenics for a while, but the most prominent voice linking the current GOP-led efforts with eugenics is ACLU lawyer (and sometime Slate contributor)...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...